electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa

3 years ago

ROCKAWAY, N.J., April 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness…

Spectral Medical Announces Investor Update Conference Call

3 years ago

TORONTO, April 06, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company…

Recce Pharmaceuticals Receives Further A$973,144 Research and Development (R&D) Advance

3 years ago

SYDNEY, Australia, April 06, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing…

HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19

3 years ago

TUCSON, Ariz., April 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools…

Extendicare Announces Timing of 2023 First Quarter Results and Conference Call

3 years ago

MARKHAM, Ontario, April 06, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it…

Sweetwater Brewing Company Expands West Coast Distribution Into Nevada

3 years ago

SweetWater, Green Flash, and Alpine Beer’s Iconic Craft Beers Now Available Across 44 States in the U.S.ATLANTA, April 06, 2023…

Revolution Medicines to Present Preclinical Data at the Upcoming American Association for Cancer Research Annual Meeting 2023

3 years ago

REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted…

Arbor Biotechnologies to Present at 2023 Cell & Gene Meeting on the Med

3 years ago

CAMBRIDGE, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of…

TransCode Therapeutics to present at AACR Annual Meeting 2023

3 years ago

BOSTON, April 06, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology Company™ committed to more effectively treating…